GlassScriptPhysician profile
Ryan A Neuhaus
NPI 1417110610
$1,229.41
in general payments reported to CMS, 2019-2025
21 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $158 · 2021: $137 · 2022: $302 · 2023: $104 · 2024: $65.09 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $306.74 | 2019-2025 | |
| Organon LLC | $102.28 | 2021-2025 | Nexplanon, Jada System |
| Mayne Pharma Commercial LLC | $78.30 | 2023-2025 | |
| Mylan Pharmaceuticals INC. | $69.70 | 2020-2022 | |
| Astellas Pharma US INC | $67.96 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $64.80 | 2019-2025 | Ally II Ups |
| Aspira Women'S Health INC | $62.40 | 2022 | |
| Hologic Sales and Service, LLC | $54.00 | 2019-2024 | Fluent Fluid Management System |
| Therapeuticsmd, INC. | $51.84 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $47.53 | 2019-2021 | |
| Pfizer INC. | $42.89 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.03 | 2019-2025 | |
| Avion Pharmaceuticals | $39.18 | 2019-2022 | |
| Exeltis, USA INC. | $38.15 | 2021-2024 | Slynd |
| Scynexis, INC. | $33.38 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $30.73 | 2022-2024 | |
| Genzyme Corporation | $27.98 | 2025 | |
| Duchesnay USA Incorporated | $23.91 | 2019 | |
| Shield Therapeutics INC | $21.31 | 2025 | |
| Amgen INC. | $12.65 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Neuhaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.